BiotechTube
Home/Pipeline/AMEND™ Transseptal Delivery System

AMEND™ Transseptal Delivery System

Mitral Regurgitation

Early FeasibilityActive

Key Facts

Indication
Mitral Regurgitation
Phase
Early Feasibility
Status
Active
Company
Valcare Medical

About Valcare Medical

Innovative transcatheter mitral valve repair platform targeting minimally invasive treatment of mitral regurgitation.

View full company profile

Therapeutic Areas

CardiovascularStructural Heart Disease

Other Mitral Regurgitation Drugs

DrugCompanyPhase
MIA-M Percutaneous Annuloplasty SystemMicro Interventional DevicesPre-clinical
AMEND™ Annuloplasty RingValcare MedicalEarly Feasibility